255 related articles for article (PubMed ID: 32946161)
1. An overview on synthetic and pharmaceutical prospective of pyrido[2,3-d]pyrimidines scaffold.
Yadav P; Shah K
Chem Biol Drug Des; 2021 Mar; 97(3):633-648. PubMed ID: 32946161
[TBL] [Abstract][Full Text] [Related]
2. An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Cherukupalli S; Hampannavar GA; Chinnam S; Chandrasekaran B; Sayyad N; Kayamba F; Reddy Aleti R; Karpoormath R
Bioorg Med Chem; 2018 Jan; 26(2):309-339. PubMed ID: 29273417
[TBL] [Abstract][Full Text] [Related]
3. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
Gangjee A; Adair OO; Queener SF
J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
6. Synthetic and medicinal perspective of thiazolidinones: A review.
Kaur Manjal S; Kaur R; Bhatia R; Kumar K; Singh V; Shankar R; Kaur R; Rawal RK
Bioorg Chem; 2017 Dec; 75():406-423. PubMed ID: 29102723
[TBL] [Abstract][Full Text] [Related]
7. An improved synthesis of pyrido[2,3-d]pyrimidin-4(1H)-ones and their antimicrobial activity.
Fares M; Abd El Hadi SR; Eladwy RA; Shoun AA; Abdel-Aziz MM; Eldehna WM; Abdel-Aziz HA; Keller PA
Org Biomol Chem; 2018 May; 16(18):3389-3395. PubMed ID: 29671455
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of some pyrido[2,3-
Abbas SE; George RF; Samir EM; Aref MM; Abdel-Aziz HA
Future Med Chem; 2019 Sep; 11(18):2395-2414. PubMed ID: 31544523
[No Abstract] [Full Text] [Related]
9. Synthesis and biological evaluation of some thio containing pyrrolo [2,3-d]pyrimidine derivatives for their anti-inflammatory and anti-microbial activities.
Mohamed MS; Kamel R; Fatahala SS
Eur J Med Chem; 2010 Jul; 45(7):2994-3004. PubMed ID: 20399543
[TBL] [Abstract][Full Text] [Related]
10. Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold.
Elzahabi HSA; Nossier ES; Khalifa NM; Alasfoury RA; El-Manawaty MA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):546-557. PubMed ID: 29482389
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents.
Naresh Kumar R; Poornachandra Y; Nagender P; Mallareddy G; Ravi Kumar N; Ranjithreddy P; Ganesh Kumar C; Narsaiah B
Eur J Med Chem; 2016 Jan; 108():68-78. PubMed ID: 26629861
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies.
El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA
Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271
[TBL] [Abstract][Full Text] [Related]
13. Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents.
Prachayasittikul S; Pingaew R; Worachartcheewan A; Sinthupoom N; Prachayasittikul V; Ruchirawat S; Prachayasittikul V
Mini Rev Med Chem; 2017; 17(10):869-901. PubMed ID: 27670581
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of substituted-4,5,6,7-tetrahydrothieno pyridines: a review.
Sangshetti JN; Zambare AS; Khan FA; Gonjari I; Zaheer Z
Mini Rev Med Chem; 2014; 14(12):988-1020. PubMed ID: 25373848
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
El-Sayed Ali T
Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel thiazolo[4,5-d]pyrimidine derivatives for antimicrobial, anti-HIV and anticancer investigation.
Rida SM; Habib NS; Badawey EA; Fahmy HT; Ghozlan HA
Pharmazie; 1996 Dec; 51(12):927-31. PubMed ID: 8985982
[TBL] [Abstract][Full Text] [Related]
17. Pyrido[2, 3-d]pyrimidines and pyrimido[5',4':5, 6]pyrido[2, 3-d]pyrimidines as new antiviral agents: synthesis and biological activity.
Nasr MN; Gineinah MM
Arch Pharm (Weinheim); 2002 Jun; 335(6):289-95. PubMed ID: 12210772
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives.
Fargualy AM; Habib NS; Ismail KA; Hassan AM; Sarg MT
Eur J Med Chem; 2013 Aug; 66():276-95. PubMed ID: 23811090
[TBL] [Abstract][Full Text] [Related]
19. Recent Developments on the Synthesis and Biological Activities of Fused Pyrimidinone Derivatives.
Seboletswe P; Awolade P; Singh P
ChemMedChem; 2021 Jul; 16(13):2050-2067. PubMed ID: 33724717
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]